Ocular biodistribution of cysteamine delivered by a sustained release microsphere/thermoresponsive gel eyedrop.

[1]  Test No. 405: Acute Eye Irritation/Corrosion , 2021, OECD Guidelines for the Testing of Chemicals, Section 4.

[2]  M. Fedorchak,et al.  A sustained release cysteamine microsphere/thermoresponsive gel eyedrop for corneal cystinosis improves drug stability , 2021, Drug delivery and translational research.

[3]  C. Charcosset,et al.  Challenges for cysteamine stabilization, quantification, and biological effects improvement , 2020, Journal of pharmaceutical analysis.

[4]  A. Chauhan,et al.  Novel approaches for improving stability of cysteamine formulations , 2018, International journal of pharmaceutics.

[5]  M. Frenneaux,et al.  A robust and versatile mass spectrometry platform for comprehensive assessment of the thiol redox metabolome , 2018, Redox biology.

[6]  Achini K. Makuloluwa,et al.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review , 2018, Clinical ophthalmology.

[7]  J. Schuman,et al.  Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop , 2017, Scientific Reports.

[8]  F. Otero-Espinar,et al.  Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging. , 2017, International journal of pharmaceutics.

[9]  V. Tasic,et al.  Worldwide view of nephropathic cystinosis: results from a survey from 30 countries , 2017, BMC Nephrology.

[10]  C. Baudouin,et al.  A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study. , 2017, Investigative ophthalmology & visual science.

[11]  K. Lyseng-Williamson.  Cystadrops® (cysteamine hydrochloride 0.55% viscous eye-drops solution) in treating corneal cystine crystal deposits in patients with cystinosis: a profile of its use , 2017 .

[12]  M. Fedorchak,et al.  Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model , 2016, Translational vision science & technology.

[13]  J. Jester,et al.  Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis. , 2016, Molecular pharmaceutics.

[14]  N. Calcutt,et al.  Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation. , 2015, Investigative ophthalmology & visual science.

[15]  V. Hampshire,et al.  Using the facial grimace scale to evaluate rabbit wellness in post-procedural monitoring , 2015, Lab Animal.

[16]  C. Baudouin,et al.  Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study. , 2015, Investigative ophthalmology & visual science.

[17]  Baoqin Lin,et al.  Ocular pharmacokinetics of naringenin eye drops following topical administration to rabbits. , 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[18]  Tove Tuntland,et al.  Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research , 2014, Front. Pharmacol..

[19]  P. Rioux,et al.  Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery , 2014, Fundamental & clinical pharmacology.

[20]  G. Deschênes,et al.  A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study. , 2014, Molecular genetics and metabolism.

[21]  M. Varga.  The rabbit-friendly practice , 2014 .

[22]  A. Chauhan,et al.  Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[23]  W. Gahl,et al.  Cysteamine ophthalmic solution 0.44% for the treatment of corneal cystine crystals in cystinosis , 2013 .

[24]  P. Flecknell,et al.  Evaluation of EMLA Cream for Preventing Pain during Tattooing of Rabbits: Changes in Physiological, Behavioural and Facial Expression Responses , 2012, PloS one.

[25]  B. Buchan,et al.  Gel formulations for treatment of the ophthalmic complications in cystinosis. , 2010, International journal of pharmaceutics.

[26]  P. Khaw,et al.  Accuracy of intraocular pressure measurements in new zealand white rabbits. , 2005, Investigative ophthalmology & visual science.

[27]  M. Kaiser-Kupfer,et al.  A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis , 2003, The British journal of ophthalmology.

[28]  C. Antignac,et al.  Intralysosomal Cystine Accumulation in Mice Lacking Cystinosin, the Protein Defective in Cystinosis , 2002, Molecular and Cellular Biology.

[29]  W. Gahl,et al.  Cystinosis. , 2002, The New England journal of medicine.

[30]  E. Kuehl,et al.  Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. , 2000, Molecular genetics and metabolism.

[31]  E. Kuehl,et al.  A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. , 1998, Molecular genetics and metabolism.

[32]  W Steiling,et al.  A critical review of the assessment of eye irritation potential using the draize rabbit eye test , 1998, Journal of applied toxicology : JAT.

[33]  M. Spencer,et al.  A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis , 1991, Eye.

[34]  E. Kuehl,et al.  A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. , 1990, Archives of ophthalmology.

[35]  M. Kaiser-Kupfer,et al.  Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. , 1987, The New England journal of medicine.

[36]  P. Conquet,et al.  A method for the routine intraocular pressure (IOP) measurement in the rabbit: range of IOP variations in this species. , 1977, Experimental eye research.